Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A randomized controlled study of the efficacy of tadalafil monotherapy versus combination of tadalafil and mirabegron for the treatment of persistent overactive bladder symptoms in men presenting with lower urinary tract symptoms (CONTACT Study)1 passage
• A systematic and comprehensive review of the role of microbiota in urinary chronic pelvic pain syndrome1 passage
• A systematic review of best practices for the perioperative management of abdominal sacrocolpopexy1 passage
• Best practice policy statement on urodynamic antibiotic prophylaxis in the non-index patient1 passage
• Bladder Function and Safety of Vibegron in Men With Overactive Bladder Receiving Treatment for Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial1 passage
• Detailed analysis of adverse events and surgical interventions in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients1 passage
• Incidence of Overactive Bladder Symptoms and Dysuria Following Transurethral Interventions for Benign Prostatic Enlargement: A Systematic Review and Meta-Analysis of Comparative and Randomized Studies1 passage
• Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation1 passage
• Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS)1 passage
• Is sacral neuromodulation effective and safe in pregnancy? A systematic review1 passage
• Melatonin and melatonin receptor agonists in the treatment of nocturia: A systematic review1 passage
• Minimum standards for continence care in the UK1 passage
• Optimal Duration of Hydrodistension for Symptomatic Treatment of Interstitial Cystitis: A Systematic Review1 passage
• Role of Gynecologic Findings in Interstitial Cystitis/Bladder Pain Syndrome: A Consensus1 passage
• Safety and efficacy of an α(1) -blocker plus mirabegron compared with an α(1) -blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta-analysis1 passage
• Stress Urinary Incontinence Treatment With Microablative Radiofrequency, Pelvic Floor Muscle Training or Combination of Both Techniques in Climacteric Women: Randomized Controlled Trial 6-Month Follow-Up1 passage
• The Efficacy and Safety of Dimethyl Sulfoxide Into the Bladder for the Treatment of Interstitial Cystitis/Bladder Pain Syndrome: A Systematic Review and Meta-Analysis1 passage
• The urinary and prostatic microbiome in non-neurogenic male LUTS/BPH: A systematic review1 passage